Metlife Inc. buy melinda
Summary
This prediction ended on 16.08.17 with a price of €47.86. The BUY prediction by melinda finished with a performance of 5.12%. melinda has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Metlife Inc. | -1.549% | -1.549% | -12.596% | 0.778% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% | 113.046% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% | 47.267% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% | 68.687% |